Aino Health AB (publ): The Offer in Aino Health AB (publ) heavily oversubscribed
(Thomson Reuters ONE) -
PRESS RELEASE
December 9, 2016
NOT FOR DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, TO NEWS
DISTRIBUTORS IN THE UNITED STATES, OR FOR DISTRIBUTION IN OR INTO THE UNITED
STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SINGAPORE, SOUTH
AFRICA OR ANY OTHER JURISDICTION WHERE SUCH DISTRIBUTION OR PUBLICATION WOULD
NOT BE ALLOWED BY APPLICABLE LAW.
Aino Health AB (publ) ("Aino Health" or the "Company") has completed the Offer
to the market to subscribe for shares in the Company for a total of 53.8 MSEK
(the "Offer"), distributed on a share issue of 46.8 MSEK (the "Share Issue") and
an Over-allotment of existing shares of 7.0 MSEK for stabilization activities
(the "Over-allotment"). The Over-allotment including stabilization of the share
price during 30 calendar days may imply that Aino Health will receive an
addition of 7.0 MSEK through a share issue included in the Over-allotment option
directed to Erik Penser Bank AB, after which the Company would receive up to
48.8 MSEK.
The Offer attracted strong interest and was subscribed to about 206 percent,
equivalent to 2.1 times the Offer. Due to the strong interest shares have been
allocated to around 1 100 new shareholders among almost 4 000 applicants. First
day of trading Aino Health's shares is scheduled for Friday December 16, 2016.
November 27, 2016, the Board of Directors in Aino Health published the decision
to apply for listing of the Company's shares on Nasdaq First North, and in
connection with the listing the Board of Directors decided to diversify the
ownership through a Share Issue according to the Offer. The Offer consists of
1,800,000 newly issued shares and an Over-allotment of 270,000 existing shares
as a part of the stabilization of the share price during 30 calendar days. The
Company may receive an addition of 270,000 shares through the Over-allotment
option directed to Erik Penser Bank as a part of the agreed stabilization of the
share price.
The number of shares will increase from 3,622,770 to 5,422,770 through the Share
Issue and up to 5,692,770 shares if the Over-allotment is fully exercised. The
dilution for existing shareholders amounts to 33.2 percent and to a maximum of
36.2 percent if the Over-allotment option is fully exercised.
The Offer implies that the Company will be added around 1 100 new shareholders,
after which the total number of shareholders will amount to approximately
1 200. The Company will meet the share distribution requirements on Nasdaq First
North and the first day of trading is scheduled for Friday December 16, 2016.
The subscription period for the Offer expired on Thursday, December 8, 2016. A
number of institutional partners and private investors have, before the
initiated subscription period, undertaken to subscribe for shares in the Share
Issue corresponding to approximately 31.9 MSEK, or about 86 percent of the Share
Issue.
The Board of Directors in Aino Health has, in consultation with Erik Penser
Bank, decided on the allotment of shares in the Offer, in which the objective
has been to achieve a good distribution of the share to enable a regular and
liquid trading on Nasdaq First North as well as achieving a desired strategic
ownership base. The allotment decision will be obtained in the form of a
contract note. Information will not be sent to those who have not been allotted
shares.
After the Offer has been registered at the Swedish Companies Registration Office
the total number of shares in Aino Health will increase by 1,800,000 shares from
3,622,770 shares to 5,422,770 shares. The share capital will increase by
4,500,000 SEK to 13,556,925 SEK. If the Over-allotment option is fully
exercised, this implies an additional increase of 270,000 shares and an increase
of the share capital of 675,000 SEK to 14,231,925 SEK.
"We are very pleased with the great interest we have had in Aino Health's IPO.
While we have secured capital for our expansion into Europe with focus on Sweden
and Germany as the first countries, we have received a large number of new
shareholders. We are very happy for this and the legitimacy that our listing
gives in various customer contacts", says Jyrki Eklund, CEO of Aino Health
Advisers
Erik Penser AB is the financial advisor and Advokatfirman Lindahl KB is the
legal adviser in the Offer and listing on Nasdaq First North. Erik Penser AB is
Certified Adviser to the Company.
Important information
Publication and distribution of this press release may in certain jurisdictions
be restricted by law and persons in those jurisdictions where this press release
has been published or distributed should inform themselves about and follow such
restrictions. The information in this press release is not an offer to acquire,
subscribe for or otherwise trade in shares or another security in Aino Health.
This press release may not be released, published or distributed, directly or
indirectly, in or into the United States, Australia, Hong Kong, Japan, Canada,
New Zealand, Singapore, South Africa or another country where such action
requires further measures in addition to what follows from Swedish law or where
this would contravene with laws or regulations of that country. The information
in this press release may not be forwarded, reproduced or disclosed in ways that
conflict with such restrictions. Omission to follow this instruction may
constitute a violation of the United States Securities Act of 1933 (the
"Securities Act") in its present terms or applicable laws in other
jurisdictions.
This information is such information that Aino Health AB (publ) is obliged to
make public pursuant to the EU Market Abuse Regulation. The information was
submitted for publication, through the agency of the contact person set out
above, at December 9 CET on 8:30 2016.
For more information, please contact:
Jyrki Eklund, CEO
Phone: +358 40 042 4221
E-mail: jyrki.eklund(at)ainohealth.com
Cecilia Hollerup, Chairman of the Board of Directors
Phone: +46 70 829 33 36
E-mail: cecilia.hollerup(at)holleruppartners.se
About Aino Health
Aino Health operates within Corporate Health Management. The company has
developed a complete system of IT-based services with a focus to improve
corporate health and reduce sickness absence levels in private and public
organizations.
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Aino Health AB (publ) via GlobeNewswire
Unternehmensinformation / Kurzprofil:
Datum: 09.12.2016 - 08:30 Uhr
Sprache: Deutsch
News-ID 511873
Anzahl Zeichen: 7600
contact information:
Town:
Lund
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 202 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Aino Health AB (publ): The Offer in Aino Health AB (publ) heavily oversubscribed"
steht unter der journalistisch-redaktionellen Verantwortung von
Aino Health AB (publ) (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
